RS

Robert J. Steffan

AP Amerimas Home Products: 19 patents #28 of 715Top 4%
Pfizer: 9 patents #561 of 5,153Top 15%
📍 Langhorne, PA: #7 of 299 inventorsTop 3%
🗺 Pennsylvania: #2,031 of 74,527 inventorsTop 3%
Overall (All Time): #139,934 of 4,157,543Top 4%
28
Patents All Time

Issued Patents All Time

Showing 1–25 of 28 patents

Patent #TitleCo-InventorsDate
7598286 [(1H-indazol-3-yl)methyl]phenols and (hydroxyphenyl)(1H-indazol-3-yl)methanones Edward Matelan 2009-10-06
7592363 Indazoles Edward Matelan, Stephen Bowen, John W. Ullrich, Jay E. Wrobel, Edouard Zamaratski +7 more 2009-09-22
7585871 Phenanthridine carbonyl phenols William J. Moore, Eugene J. Trybulski, Albert J. Molinari 2009-09-08
7241791 Substituted 4-(indazol-3-yl)phenols Edward Matelan, Mark Anthony Ashwell, William Ronald Solvibile 2007-07-10
6936630 Substituted 1-aryl-3-heteroaryl-thioureas and substituted 1-aryl-3-heteroaryl-isothioureas as antiatherosclerotic agents Amedeo A. Failli 2005-08-30
6686476 Substituted 1-aryl-3-heteroaryl-thioureas and substituted 1-aryl-3-heteroaryl-isothioureas as antiatherosclerotic agents Amedeo A. Failli 2004-02-03
6620807 Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists Amedeo A. Failli 2003-09-16
6506901 Substituted 2-(S)-hydroxy-3-(piperidin-4-yl-methylamino)-propyl ethers and substituted 2-aryl-2-(R)-hydroxy-1-(piperidin-4-yl-methyl)-ethylamine &bgr;-3 adrenergic receptor agonists Mark Anthony Ashwell, Jeffrey Claude Pelletier, William Ronald Solvibile, Edward Matelan 2003-01-14
6455566 Substituted 1-aryl-3-heteroaryl-thioureas (or isothioureas) as antiatherosclerotic agents Amedeo A. Failli 2002-09-24
6344451 Pyrrolobenzodiazepine carboxyamide vasopressin agonists Amedeo A. Failli 2002-02-05
6268364 Substitued tetrahydro-1,3,5-triazin-2[1H]-thiones as anti-atherosclerotic agents Kevin A. Memoli, Donald P. Strike, Amedeo A. Failli 2001-07-31
6194407 Tricyclic pyrido vasopressin agonists Amedeo A. Failli, Jay S. Shumsky 2001-02-27
6160114 Substituted tetrahydro-1,3,5-triazin-2[1H]-thiones as anti-atherosclerotic agents Kevin A. Memoli, Donald P. Strike, Amedeo A. Failli 2000-12-12
6090803 Tricyclic vasopressin agonists Amedeo A. Failli, Jay S. Shumsky 2000-07-18
6011053 Substituted indole-1-carbothioic acid amides as novel antiatherosclerotic agents Amedeo A. Failli 2000-01-04
5830911 Pyranoindole and tetrahydrocarbazole inhibitors of COX-2 Amedeo A. Failli, Anthony Kreft, Thomas Joseph Caggiano, Craig E. Caufield 1998-11-03
5446048 Rapamycin oximes Amedeo A. Failli, Craig E. Caufield, David C. Hu, Alexander A. Grinfeld 1995-08-29
5389639 Amino alkanoic esters of rapamycin Amedeo A. Failli 1995-02-14
5373014 Rapamycin oximes Amedeo A. Failli, Craig E. Caufield, David C. Hu, Alexander A. Grinfeld 1994-12-13
5346893 Rapamycin 42-sulfonates and 42-(N-carbalkoxy) sulfamates useful as immunosuppressive agents Amedeo A. Failli, Wenling Kao, Robert L. Vogel 1994-09-13
5260299 Rapamycin 42-sulfonates and 42-(N-Carboalkoxy)Sulfamates Useful as Immunosuppressive Agents Amedeo A. Failli, Wenling Kao, Robert L. Vogel 1993-11-09
5252579 Macrocyclic immunomodulators Jerauld S. Skotnicki, Amedeo A. Failli, Robert M. Kearney 1993-10-12
5177203 Rapamycin 42-sulfonates and 42-(N-carboalkoxy) sulfamates useful as immunosuppressive agents Amedeo A. Failli, Wenling Kao, Robert L. Vogel 1993-01-05
5164399 Rapamycin pyrazoles Amedeo A. Failli 1992-11-17
5162333 Aminodiesters of rapamycin Amedeo A. Failli 1992-11-10